LoginLogin RegisterRegister
Ivey Publishing
Schering Plough: Replacing Claritin
Product Number:
9B05E010
Publication Date:
07/15/2005
Revised Date:
09/30/2009
Length:
5 pages
Product Type:
Case (Library)
Source:
Ivey
Schering Plough is a large pharmaceutical company with over 22,000 employees worldwide, and over $6.8 billion in sales worldwide. The company is considering two options to replace its flagship drug, Claritin (an antihistamine), as Claritin's patent is soon to expire. One drug is targeted toward nasal congestion, the other towards asthma; however, each drug is at a different stage in the development process, one has greater market potential but was still in its early development stage, the other drug could be launched within the year but would appeal to a much smaller market. The company must decide which drug to pursue or whether to focus on both drugs or neither. The case allows students to do a traditional NPV analysis and decision analysis and the use of simulation.
Issues:
Net Present Value Method; Real Options; Simulation; Decision Analysis
Disciplines:
Management Science,  Information Systems
Industries:
Manufacturing
Setting:
United States, Large, 1997
Intended Audience:
Undergraduate/MBA
Price:
$3.95 CAD / $3.95 USD Printed Copy
$3.40 CAD / $3.40 USD Permissions
$3.40 CAD / $3.40 USD Digital Download
You Might Also Like...

Save In: